Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Verrienti

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
International Journal of Oncology|April 11, 2017
MicroRNA-based molecular classification of papillary thyroid carcinomaFrancesca Rosignolo, Lorenzo Memeo, Fabio Monzani, et al.
Molecular and Cellular Endocrinology|May 13, 2014
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumoursMarialuisa Sponziello, Cosimo Durante, Amelie Boichard, et al.
Endocrine|April 4, 2015
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cellsMarialuisa Sponziello, Antonella Verrienti, Francesca Rosignolo, et al.
Endocrine|March 25, 2020
Correction to: Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinomaRosa Falcone, Marialuisa Sponziello, Raffella Carletti, et al.
Endocrine-Related Cancer|July 13, 2016
RET mutation and increased angiogenesis in medullary thyroid carcinomasAntonella Verrienti, Giovanni Tallini, Chiara Colato, et al.
Human Mutation|December 9, 2017
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancerMarialuisa Sponziello, Silvia Benvenuti, Alessandra Gentile, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 4, 2006
Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relativesMargherita Bonamico, Mirella Ferri, Paolo Mariani, et al.
Clinical Epigenetics|March 31, 2021
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedsideFederica Sarno, Giuditta Benincasa, Markus List, et al.
Biomarker Research|September 19, 2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic valueAnna Citarella, Zein Mersini Besharat, Sofia Trocchianesi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2015
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical studyGiovanni Tallini, Dario de Biase, Cosimo Durante, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
International Journal of Oncology|April 11, 2017
MicroRNA-based molecular classification of papillary thyroid carcinomaFrancesca Rosignolo, Lorenzo Memeo, Fabio Monzani, et al.
Molecular and Cellular Endocrinology|May 13, 2014
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumoursMarialuisa Sponziello, Cosimo Durante, Amelie Boichard, et al.
Endocrine|April 4, 2015
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cellsMarialuisa Sponziello, Antonella Verrienti, Francesca Rosignolo, et al.
Endocrine|March 25, 2020
Correction to: Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinomaRosa Falcone, Marialuisa Sponziello, Raffella Carletti, et al.
Endocrine-Related Cancer|July 13, 2016
RET mutation and increased angiogenesis in medullary thyroid carcinomasAntonella Verrienti, Giovanni Tallini, Chiara Colato, et al.
Human Mutation|December 9, 2017
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancerMarialuisa Sponziello, Silvia Benvenuti, Alessandra Gentile, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 4, 2006
Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relativesMargherita Bonamico, Mirella Ferri, Paolo Mariani, et al.
Clinical Epigenetics|March 31, 2021
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedsideFederica Sarno, Giuditta Benincasa, Markus List, et al.
Biomarker Research|September 19, 2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic valueAnna Citarella, Zein Mersini Besharat, Sofia Trocchianesi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2015
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical studyGiovanni Tallini, Dario de Biase, Cosimo Durante, et al.
Pageof 6